Literature DB >> 16299145

Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants.

A Lecleire-Collet1, L H Tessier, P Massin, V Forster, G Brasseur, J A Sahel, S Picaud.   

Abstract

BACKGROUND/AIMS: Neuronal degeneration has been reported to occur in diabetic retinopathy before the onset of detectable microvascular abnormalities. To investigate whether advanced glycation end products (AGE) could be directly responsible for retinal neurodegeneration, retinal explants were incubated with glycated bovine serum albumin (BSA).
METHODS: Retinal explants obtained from non-diabetic adult rats were incubated 4 days with or without 200 mug/ml glycated BSA. Neural apoptosis was quantified by terminal dUTP nick end labelling (TUNEL) binding and immunostaining with anti-cleaved caspase-3 antibody. Expression of glial fibrillary acidic protein (GFAP) was localised by immunofluorescence.
RESULTS: TUNEL and cleaved caspase-3 positive cells increased significantly by 2.2-fold and 2.5-fold in retinal explants incubated in glycated BSA (p<0.05), respectively. The ganglion cell layer was the most sensitive retinal layer to the glycated BSA. Neuronal degeneration was confirmed by the increased GFAP labelling in Müller glial cells from retinal explants treated with glycated BSA.
CONCLUSION: These results suggest that AGE could induce retinal neurodegeneration in the absence of blood perfusion. Cells in the ganglion cell layer appeared to be the most sensitive as in diabetic retinopathy and its animal models. AGE toxicity could therefore contribute to the early pathological mechanisms of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299145      PMCID: PMC1772999          DOI: 10.1136/bjo.2005.079491

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

1.  Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.

Authors:  T Soulis; V Thallas; S Youssef; R E Gilbert; B G McWilliam; R P Murray-McIntosh; M E Cooper
Journal:  Diabetologia       Date:  1997-06       Impact factor: 10.122

2.  Light-induced photoreceptor apoptosis in vivo requires neuronal nitric-oxide synthase and guanylate cyclase activity and is caspase-3-independent.

Authors:  M Donovan; R J Carmody; T G Cotter
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

3.  An RCS-like retinal dystrophy phenotype in mer knockout mice.

Authors:  Jacque L Duncan; Matthew M LaVail; Douglas Yasumura; Michael T Matthes; Haidong Yang; Nikolaus Trautmann; Aimee V Chappelow; Wei Feng; H Shelton Earp; Glenn K Matsushima; Douglas Vollrath
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

4.  Dye-induced photolesion in the mammalian retina: glial and neuronal reactions.

Authors:  S Picaud; L Peichl; N Franceschini
Journal:  J Neurosci Res       Date:  1993-08-15       Impact factor: 4.164

5.  Isolation and characterization of galectins in the mammalian retina.

Authors:  F Uehara; N Ohba; M Ozawa
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

6.  Advanced glycation end products increase retinal vascular endothelial growth factor expression.

Authors:  M Lu; M Kuroki; S Amano; M Tolentino; K Keough; I Kim; R Bucala; A P Adamis
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

7.  Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection.

Authors:  Friedemann Reber; Romy Geffarth; Michael Kasper; Andreas Reichenbach; Erwin D Schleicher; Axel Siegner; Richard H W Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-07       Impact factor: 3.117

Review 8.  The role of advanced glycation in the pathogenesis of diabetic retinopathy.

Authors:  Alan W Stitt
Journal:  Exp Mol Pathol       Date:  2003-08       Impact factor: 3.362

9.  Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina.

Authors:  S-H Park; J-W Park; S-J Park; K-Y Kim; J-W Chung; M-H Chun; S-J Oh
Journal:  Diabetologia       Date:  2003-07-31       Impact factor: 10.122

Review 10.  A new view of diabetic retinopathy: a neurodegenerative disease of the eye.

Authors:  Alistair J Barber
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-04       Impact factor: 5.067

View more
  17 in total

1.  Diabetes-related adduct formation and retinopathy.

Authors:  Alan W Stitt; Timothy M Curtis
Journal:  J Ocul Biol Dis Infor       Date:  2011-12-28

2.  Quantitative analysis of early retinal vascular changes in type 2 diabetic patients without clinical retinopathy by optical coherence tomography angiography.

Authors:  Muhammed Altinisik; Neslihan Sinim Kahraman; Emin Kurt; Huseyin Mayali; Ozcan Kayikcioglu
Journal:  Int Ophthalmol       Date:  2022-01-31       Impact factor: 2.031

Review 3.  Primary retinal cultures as a tool for modeling diabetic retinopathy: an overview.

Authors:  Andrea Matteucci; Monica Varano; Cinzia Mallozzi; Lucia Gaddini; Marika Villa; Sara Gabrielli; Giuseppe Formisano; Flavia Pricci; Fiorella Malchiodi-Albedi
Journal:  Biomed Res Int       Date:  2015-01-19       Impact factor: 3.411

4.  Litsea japonica extract inhibits neuronal apoptosis and the accumulation of advanced glycation end products in the diabetic mouse retina.

Authors:  Junghyun Kim; Chan-Sik Kim; Yun Mi Lee; Eunjin Sohn; Kyuhyung Jo; Jin Sook Kim
Journal:  Mol Med Rep       Date:  2015-03-24       Impact factor: 2.952

5.  Diabetic macular morphology changes may occur in the early stage of diabetes.

Authors:  Yanwei Chen; Jianfang Li; Yan Yan; Xi Shen
Journal:  BMC Ophthalmol       Date:  2016-01-18       Impact factor: 2.209

6.  KIOM-79 protects AGE-induced retinal pericyte apoptosis via inhibition of NF-kappaB activation in vitro and in vivo.

Authors:  Junghyun Kim; Chan-Sik Kim; Eunjin Sohn; Yun Mi Lee; Kyuhyung Jo; Jin Sook Kim
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

7.  The proinflammatory cytokine high-mobility group box-1 mediates retinal neuropathy induced by diabetes.

Authors:  Ahmed M Abu El-Asrar; Mohammad Mairaj Siddiquei; Mohd Imtiaz Nawaz; Karel Geboes; Ghulam Mohammad
Journal:  Mediators Inflamm       Date:  2014-03-10       Impact factor: 4.711

8.  Neuronal cell death and regeneration in diseases associated with advanced glycation end-products accumulation.

Authors:  Guzel Bikbova; Toshiyuki Oshitari; Shuichi Yamamoto
Journal:  Neural Regen Res       Date:  2014-04-01       Impact factor: 5.135

9.  Injury of cortical neurons is caused by the advanced glycation end products-mediated pathway.

Authors:  Ying Xing; Xu Zhang; Xiangfu Song; Zhongwen Lv; Lingling Hou; Fei Li
Journal:  Neural Regen Res       Date:  2013-04-05       Impact factor: 5.135

10.  Zerumbone, a Phytochemical of Subtropical Ginger, Protects against Hyperglycemia-Induced Retinal Damage in Experimental Diabetic Rats.

Authors:  Thing-Fong Tzeng; Shorong-Shii Liou; Yu-Cheng Tzeng; I-Min Liu
Journal:  Nutrients       Date:  2016-07-25       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.